bioRxivMolecular BiologyPreprint
Loss of SDHB reprograms energy metabolisms and inhibits high fat diet induced metabolic syndromes
Chenglong MuiD, Biao Ma, Chuanmei ZhangiD, Guangfeng GengiD, Xinling Zhang, Linbo CheniD, Meng Wang, Jie LiiD, Tian ZhaoiD, Hongcheng Cheng, Qianping ZhangiD, Kaili MaiD, Qian LuoiD, Rui Chang, Qiangqiang LiuiD, Hao WuiD, Lei LiuiD, Xiaohui WangiD, Jun Wang, Yong ZhangiD, Yungang Zhao, Li Wen, Quan CheniD, Yushan ZhuiD
Abstract
Mitochondrial respiratory complex II utilizes succinate, key substrate of the Krebs cycle, for oxidative phosphorylation, which is essential for glucose metabolism. Mutations of complex II cause cancers and mitochondrial diseases, raising a critical question of the (patho-)physiological functions. To address the fundamental role of complex II in systemic energy metabolism, we specifically knockout SDHB in mice liver, a key complex II subunit that tethers the catalytic SDHA subunit and transfers the electrons to ubiquinone, and found that SHDB deficiency abolishes the assembly of complex II without affecting other respiration complexes while largely retaining SDHA stability. SHDB ablation reprograms energy metabolism and hyperactivates the glycolysis, Krebs cycle and {beta}-oxidation pathways, leading to catastrophic energy deficit and early death. Strikingly, sucrose supplementation or high fat diet resumes both glucose and lipid metabolism and prevent early death. Also, SDHB deficient mice are completely resistant to high fat diet induced obesity. Our findings reveal that the unanticipated role of complex II orchestrating both lipid and glucose metabolisms, and suggest that SDHB is an ideal therapeutic target for combating obesity.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways
Aneta Stachowicz, Klaudia Czepiel, … Rafał Olszanecki·bioRxiv·Apr 17, 2024
- Inhibition of mammalian mtDNA transcription paradoxically activates liver fatty acid oxidation to reverse diet-induced hepatosteatosis and obesity
S. Jiang, T. Yuan, … N.-G. Larsson·bioRxiv·Sep 22, 2023
- Impaired mitochondrial ketone body oxidation in insulin resistant states
Elric Zweck, Sarah Piel, … Cesare Granata·EBioMedicinePeer-reviewed·Nov 13, 2025
- The hepatic compensatory response to elevated systemic sulfide promotes diabetes
R. N. Carter, M. T. G. Gibbins, … N. M. Morton·bioRxiv·Apr 27, 2020
- NADH dehydrogenase reverses dietary and clock metabolic syndrome
Chelsea Hepler, Nathan J. Waldeck, … Joseph T. Bass·bioRxiv·Oct 22, 2025
- Mitochondrial Redox Adaptations Enable Aspartate Synthesis in SDH-deficient Cells
M. L. Hart, E. Quon, … L. B. Sullivan·bioRxiv·Mar 14, 2022